Dx Deals: Quest Closes PathAI Partial Acquisition and Strategic Alliance
Deal is expected to give the lab giant a big boost in deploying artificial intelligence in the pathology space.
Keeps You Up-to-Date on Lab Business and Competitive Strategy, Market Trends and Opportunities, and M&A and Investment Activity in Today’s Diagnostic Lab Industry
Deal is expected to give the lab giant a big boost in deploying artificial intelligence in the pathology space.
From - Laboratory Industry Report
LabCorp has received emergency approval from the U.S. Food and Drug Administration for a molecular-based rapid detection test for…
From - Laboratory Industry Report
The California-based molecular laboratory Veracyte has published a new study suggesting its Percepta bronchial genomic test can reduce the rate of…